Test Code: ONC002
Von Hippel Lindau syndrome
Oncogenetics
Von Hippel–Lindau (VHL) syndrome is a hereditary condition that increases the risk of developing tumours and cysts in multiple organs, including the brain, spinal cord, eyes, kidneys, pancreas, and adrenal glands. It is caused by pathogenic variants in the VHL gene and follows autosomal dominant inheritance, meaning each child of an affected individual has a 50% chance of inheriting the condition. Our VHL Genetic Test provides comprehensive analysis of the VHL gene using advanced next‑generation sequencing (NGS) and deletion/duplication testing. This enables accurate detection of variants associated with VHL syndrome, supporting early diagnosis, personalised surveillance, and proactive management.
Sample Type
Blood in EDTA; Bone marrow (Na Heparin Tube)
Turnaround Time
3 - 4 weeks days
Courier Requirements
Ship overnight at room temperature to receive next day. Maintain specimen at room temperature.
Pricing
Login to view pricing
Genes Analyzed
1 genes
VHL1
Methodology
Capture-based target enrichment and Next Generation Sequencing.
Need Help with This Test?
Our team of board-certified genomic scientists is available to answer your questions about test selection, sample requirements, and result interpretation.